FFP-102

N/A

Report date: 2025/01/02 20:00:07

Base Information

Drug NameFFP-102

Drug Alias Name5-D12PG-102

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 inhibitors

TargetsTumor necrosis factor receptor superfamily member 5

Therapy Area/IndicationsArthritis, Psoriatic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySerbia

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPangenetics

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsArthritis, Psoriatic

ATC CodeN/A